Pfizer's Abrocitinib Receives Positive CHMP Opinion For Atop

NEW YORK CITY (dpa-AFX) - The European Medicines Agency's or EMA Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the 100 mg and 200 mg doses of

Related Keywords

Norway , Iceland , Liechtenstein , , Pfizer , Pfizer Inc , Committee For Medicinal Products Human , European Union , European Medicines Agency , European Commission , Medicinal Products , Human Use , Abrocitinib , Eceives , Positive , Thmp , Opinion , Topic , Dermatitis , Treatment ,